China NMPA Product Recall - Implantable Left Ventricular Assist System

Abbott Medical Products (Shanghai) Co., Ltd. initiated a voluntary Class II recall of its implantable Left Ventricular Assist System, as reported by the National Medical Products Administration (NMPA) on September 2, 2024. The recall addresses a potential screen warping issue with the system controller found in certain pre-sterilized units. This issue could affect the functionality and reliability of the critical interface for the medical device. Abbott Medical proactively reported this concern, leading to the voluntary recall. It is noteworthy that the products identified in this specific recall were not imported into the Chinese market, thereby minimizing direct local impact. Comprehensive details regarding specific models, batches, and other pertinent information are provided in the associated "Medical Device Recall Event Report Form." This action highlights Abbott Medical's dedication to maintaining product quality and patient safety, aligning with NMPA regulatory standards, even for units not distributed within China.